SOS1-IN-19
SOS1-IN-19 (Compound 10i) is a potent inhibitor of SOS1 (Son of Sevenless 1) with an IC50 value of 165.2 nM. SOS1-IN-19 blocks KRAS activation by preventing GDP/GTP exchange in KRAS signaling pathway. SOS1-IN-19 is promising for research of KRAS-driven cancers (e.g., NSCLC and colorectal cancer) [1].
Product Specifications
UNSPSC
12352005
Target
SOS1
Related Pathways
MAPK/ERK Pathway
Field of Research
Cancer
Smiles
COC1=C(OC)C=C2C(N=C(N3CC(N(C)C)C3)N=C2N[C@H](C)C4=CC(N)=CC(C(F)(F)F)=C4)=C1
Molecular Formula
C24H29F3N6O2
Molecular Weight
490.52
References & Citations
[1]Chen Y, et al. Design and structural optimization of novel SOS1 inhibitors in KRAS-driven cancers. Bioorg Med Chem Lett. 2025 Sep 1;125-126:130282.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040050-100 1x 100 µL
IgA Secretory Component (SC05), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471132-500 1x 500 µL
CD45RB (PTPRC/1132), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042083-100 1x 100 µL
CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940883-100 1x 100 µL
PSA (Prostate Specific Antigen) (A67-B/E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940139-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (57), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details